Thanks to budget cuts, many potential insights and treatments needed to propel oncology forward will never be realized.

Sumitomo Pharma America, Inc. (SMPA) presented new, positive data from the COURAGE Phase 3 open-label extension study of vibegron (GEMTESA®) in men living with overactive bladder (OAB) and receiving ...

Produce high-quality, injectable drug delivery systems with the Thermo Scientific™ Pharma mini Implant Line. This automated end-to-end solution meets cGMP and FDA requirements. Accurate dosing ...

Engine Biosciences (Engine), a company pioneering cancer medicines informed by its proprietary machine learning and ...

In recognition of ALS Awareness Month this May, Target ALS is proud to launch Behind Every Breakthrough—a month-long ...

Thermo Fisher Scientific, one of the largest providers of services to the pharma industry, revealed mid-way through 2023 that it would look to cut $450 million in costs because of slowing demand.

2023 Solasia Pharma K.K. Registered Shs 0.00 0.00 JPY 2022 Solasia Pharma K.K. Registered Shs 0.00 0.00 JPY 2021 Solasia Pharma K.K. Registered Shs 0.00 0.00 JPY 2020 ...

In this article, Ben Hargreaves asks whether there is particular potential for the technologies to revolutionise staff training and reduce costs in pharma manufacturing. Virtual reality (VR ...

Arc Institute continues its work to generate and share large-scale, high-quality datasets of cell state before and after chemical or genetic perturbations to enable "virtual cell" models and other ...

More Bonds of BridgeBio Pharma Inc. About the BridgeBio Pharma Inc.-Bond (US10806XAH52) The BridgeBio Pharma Inc.-Bond has a maturity date of 3/1/2031 and offers a coupon of 1.7500%. The payment ...

Follow this link. Madison, a twelve-year-old from Illinois, visits a medical clinic every other week to get injections of Xolair, a powerful asthma and allergy medication. The drug helps protect her ...